Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

185 trials

NCT03892993
Recruiting
Patient Decision Aid in Supporting Decision-Making About When to Start or Stop New Drugs, Join Clinical Trials, or Continue Active Surveillance in Patients With Medullary Thyroid Cancer and Their Caregivers
Not applicable · United States · 1 site
Registry update: 16 Jul 2026
NCT05766098
Recruiting
Definition of Mutational Profile of Papillary Thyroid Tumors by Mass-ARRAY
Not applicable · Italy · 1 site
Registry update: 3 Nov 2026
NCT03647358
Recruiting
Lesion Dosimetry With Iodine-124 in Metastatic Thyroid Carcinoma
Phase 1 · United States · 1 site
Registry update: 10 Sept 2026
NCT07033572
Recruiting
Hybrid Endoscopic Hemithyroidectomy and Targeted Ablation for Bilateral Papillary Thyroid Carcinoma
Not applicable · China · 1 site
Registry update: 3 Jul 2025
NCT03483337
Recruiting
New MRI Biomarkers in Head and Neck Cancers
Not applicable · United States · 1 site
Registry update: 14 Apr 2026
NCT03676348
Recruiting
HRQOL in Thyroid Cancer and Thyroid Tumours
Not applicable · Norway · 1 site
Registry update: 11 Mar 2022
NCT03093909
Recruiting
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
Phase 1 · United States · 1 site
Registry update: 10 Nov 2026
NCT03175224
Recruiting
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
Phase 2 · Australia, Canada, Spain, France, United Kingdom, Hungary, Italy, Russia, Singapore, Taiwan, United States · 42 sites
Registry update: 27 Jun 2025
NCT03177902
Recruiting
Evaluation of Thyroid Abnormity Incidence and Thyroid Toxicity During Chemotherapy Among Newly Diagnosed Breast Cancer
Not applicable · China · 1 site
Registry update: 4 Sept 2026
NCT03099356
Recruiting
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
Phase 2 · United States · 1 site
Registry update: 31 Jul 2026
NCT03093116
Recruiting
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Phase 1/2 · Australia, Belgium, Canada, China, Germany, Denmark, Spain, France, United Kingdom, Hong Kong, Hungary, Italy, Japan, South Korea, Netherlands, Poland, Singapore, Taiwan, United States · 143 sites
Registry update: 27 May 2026
NCT03382158
Recruiting
International PPB/DICER1 Registry
Not applicable · United States · 1 site
Registry update: 26 Oct 2026
NCT02609685
Recruiting
Active Surveillance of Papillary Thyroid Microcarcinoma
Not applicable · United States · 1 site
Registry update: 4 Nov 2026
NCT02747888
Recruiting
Hereditary Risk Factors for Thyroid Cancer
Not applicable · United States · 1 site
Registry update: 11 Jun 2026
NCT03410394
Recruiting
Registry of Endocrine Tumors (Thyroid, Parathyroid, Adrenal, Endocrine Pancreas, Endocrine Digestive Tube)
Not applicable · France · 1 site
Registry update: 22 Oct 2026
NCT07428057
Recruiting
Postoperative Hypocalcemia After Thyroidectomy
Not applicable · Egypt · 1 site
Registry update: 22 Sept 2026
NCT02012699
Recruiting
Integrated Cancer Repository for Cancer Research
Not applicable · United States · 42 sites
Registry update: 29 Jun 2026
NCT06623500
Recruiting
Iodine Nutrition Status and Clinical Characteristics of Thyroid Cancer
Not applicable · China · 1 site
Registry update: 2 Oct 2024
NCT01247597
Recruiting
DICER1-related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural History Study
Not applicable · United States · 2 sites
Registry update: 9 Nov 2026
NCT01109420
Recruiting
Clinical and Genetic Studies in Familial Non-medullary Thyroid Cancer
Not applicable · United States · 1 site
Registry update: 9 Nov 2026

Ordered by registry start date. Freshness and sponsorship never change the order.